{"nct_id":"NCT04058353","title":"A Phase 3 Study of VX-445 Combination Therapy in Cystic Fibrosis (CF) Subjects Heterozygous for F508del and a Gating or Residual Function Mutation (F/G and F/RF Genotypes)","status":"COMPLETED","status_verified_date":"2021-06","start_date":"2019-08-28","start_date_type":"ACTUAL","primary_completion_date":"2020-06-12","primary_completion_date_type":"ACTUAL","completion_date":"2020-06-12","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["VRTX"]}